Patient Guide: Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (firmMIND)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 61 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05429268
Status: ACTIVE_NOT_RECRUITING
Condition: Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma
Phase: PHASE3

Find a Study Location Near You

This study is available at 61 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Plovdiv,
  • Sofia,
  • Sofia,
  • • And 58 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily